سوق الحقن القابلة للارتداء - النمو ، والاتجاهات ، وتأثير COVID-19 ، والتوقعات (2023 - 2028)

Table of Contents

1. 1. INTRODUCTION

   1. 1.1 Study Deliverables

   2. 1.2 Study Assumptions

   3. 1.3 Scope of the Study

2. 2. RESEARCH METHODOLOGY

3. 3. EXECUTIVE SUMMARY

4. 4. MARKET DYNAMICS

   1. 4.1 Market Overview

   2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancements and Design Development

      3. 4.2.3 Increasing Concern over the Hazards and Limitations Related to Needlestick

   3. 4.3 Market Restraints

      1. 4.3.1 Preference for Alternative Drug Delivery Modes

      2. 4.3.2 Unfavorable Reimbursement Structure in Developing Countries

   4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

5. 5. MARKET SEGMENTATION

   1. 5.1 By Type

      1. 5.1.1 On-Body Injectors

      2. 5.1.2 Off-Body Injectors

   2. 5.2 By Therapy

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Disease

      3. 5.2.3 Diabetes

      4. 5.2.4 Cardiovascular Disease

      5. 5.2.5 Others

   3. 5.3 By End User

      1. 5.3.1 Hospitals and Clinics

      2. 5.3.2 Home Care

      3. 5.3.3 Others

   4. 5.4 Geography

      1. 5.4.1 North America

         1. 5.4.1.1 United States

         2. 5.4.1.2 Canada

         3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

         1. 5.4.2.1 Germany

         2. 5.4.2.2 United Kingdom

         3. 5.4.2.3 France

         4. 5.4.2.4 Italy

         5. 5.4.2.5 Spain

         6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

         1. 5.4.3.1 China

         2. 5.4.3.2 Japan

         3. 5.4.3.3 India

         4. 5.4.3.4 Australia

         5. 5.4.3.5 South Korea

         6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

         1. 5.4.4.1 GCC

         2. 5.4.4.2 South Africa

         3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

         1. 5.4.5.1 Brazil

         2. 5.4.5.2 Argentina

         3. 5.4.5.3 Rest of South America

6. 6. COMPETITIVE LANDSCAPE

   1. 6.1 Company Profiles

      1. 6.1.1 Amgen Inc.

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 Dexcom, Inc.

      4. 6.1.4 Enable Injections

      5. 6.1.5 Insulet Corporation

      6. 6.1.6 Sensile Medical

      7. 6.1.7 Tandem Diabetes Care, Inc.

      8. 6.1.8 Ypsomed

   *List Not Exhaustive

7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS